Even as value-based contracting proliferates, the financial incentives for hospitals and medical groups to eliminate waste and improve care have barely changed.
The dictionary defines vaporware as a product that has been widely advertised but has not and may never become available. Last week's twin announcements on the imminent move to widespread value-based reimbursement in healthcare bring the concept to mind.
Holy Cross Hospital's investment in an eight-bed Seniors Emergency Center in Silver Spring, Md., increased hospital visits.
Data Points for the week of Feb. 2, 2015, covered the following topics: medical costs for chronic conditions, cervical cancer, Medicaid, coordinated care
A 10.6% increase in sales of its top-selling arthritis drug Humira still couldn't produce positive fourth-quarter earnings for drugmaker AbbVie, the Chicago-based spinoff of Abbott Laboratories.
Health spending increased 4% in the fourth quarter from the same period a year ago, the first estimate for economic growth in the final months of last year shows.
A Massachusetts judge rejected an agreement that would have allowed Partners HealthCare to acquire three hospitals, saying the expansion would allow the Boston-based system, already the largest in the state, "to exact higher prices from insurers for the services its providers render.”
Additional outreach about insurance marketplace premium subsidies and expanded eligibility standards for Medicaid is needed to reach the uninsured, a Kaiser Family Foundation study suggests.
The CMS Innovation Center's massive Comprehensive Primary Care initiative appeared to break even its first year, but there is concern that a planned reduction in its care-management fee this year could impede the fragile momentum it has built.
Thermo Fisher Scientific's earnings, following a major acquisition, soared 75.7% to $601.2 million in the three months ended Dec. 31. The company saw a nearly 50% jump in earnings for 2014, ending the year with $1.9 billion in net income.
Orthopedic implant manufacturer Zimmer Holdings reported a 1.4% drop in revenue to $1.22 billion in the fourth quarter of 2014 as worldwide sales of hip and knee implants decrease.
U.S. healthcare providers and insurers start from widely divergent places as some of the largest move to put most of their business into payment models that reward lower cost and higher quality care.